Table 3.
Demographics.
| Demographics | n = 61 |
|---|---|
| Sex | |
| Male | 23 (38%) |
| Female | 38 (62%) |
| Age | |
| 18–29 | 2 (3%) |
| 30–49 | 6 (10%) |
| 50–64 | 23 (38%) |
| 65 and older | 30 (49%) |
| Number of Concomitant Medications * | |
| 0–4 | 14 (23%) |
| 5–9 | 15 (25%) |
| 10 or greater | 21 (34%) |
* Researchers were unable to obtain full medication lists in the retrospective chart review for 2 nirmatrelvir/ritonavir and 5 molnupiravir prescriptions due to inconsistencies in documentation, but were able to obtain documented interventions for specific medication therapy problems. Furthermore, it is important to note that workflow for molnupiravir prescriptions did not require pharmacists to verify a full medication list due to no significant documented drug–drug interactions.